Le Lézard
Classified in: Health, Covid-19 virus
Subject: AVO

American Lung Association: Universal COVID-19 Antibody Testing Urgently Needed


CHICAGO, April 20, 2020 /PRNewswire/ -- The COVID-19 pandemic has resulted in unprecedented rates of lung infections and deaths in modern history. To save lives and decrease the risk of a generation of survivors with severely damaged lung health, the American Lung Association is calling for the urgent nationwide rollout of coordinated and universal COVID-19 antibody testing.

"The lives of too many have been lost, especially those most vulnerable ? the elderly, chronically ill and minority populations. Unfortunately, in addition to the deaths, we may face a generation of those who have recovered from COVID-19, but are permanently burdened with damaged lung health that will affect their productivity, quality of life and likely their longevity," said American Lung Association President and CEO Harold Wimmer. "To reduce the spread, our nation must act urgently to implement both antibody testing to identify immune individuals and nasal swab tests to identify current infections, in tandem."

"The more people you can test - both for current infections and the antibodies created by prior infections - the more accurately you can determine who's safe from the virus and who's spreading it to others," said American Lung Association Chief Medical Officer Albert Rizzo, M.D. "This containment effort becomes even more important as mitigation efforts such as social distancing are relaxed. The more you can do that, the more everyone can isolate and stop spreading the virus further to save lives and decrease the post-COVID-19 risk of chronic lung disease."

The stay-at-home orders, social distancing efforts and the all-out heroics of our front-line and essential workers in the healthcare industry has lessened the dire predictions first made regarding deaths in this country. Yet from the start of the pandemic, the lack of adequate COVID-19 antigen testing made the efforts at containment and tracking difficult. The virus spread unchecked, and with approximately 25% of those infected being minimally symptomatic or asymptomatic, unintentional and unknowing transmission of the virus accelerated the spread.

"There is a significant concern around the push to re-open the economy and send people back into the workforce without a vaccine or specific and effective treatment for COVID-19, especially if the social distancing restrictions are too relaxed or uncoordinated," said Wimmer. "The American Lung Association calls on our nation's leaders to immediately implement coordinated and universal COVID-19 testing."

For more information about COVID-19 and the American Lung Association's $25M investment in COVID-19 research, visit Lung.org/cv19-action. Journalists interested in scheduling an interview about COVID-19 and the Lung Association's efforts may contact Stephanie Goldina at 312-801-7629 or [email protected].

About the American Lung Association
The American Lung Association is the leading organization working to save lives by improving lung health and preventing lung disease through education, advocacy and research. The work of the American Lung Association is focused on four strategic imperatives: to defeat lung cancer; to champion clean air for all; to improve the quality of life for those with lung disease and their families; and to create a tobacco-free future. For more information about the American Lung Association, a holder of the coveted 4-star rating from Charity Navigator and a Gold-Level GuideStar Member, or to support the work it does, call 1-800-LUNGUSA (1-800-586-4872) or visit: Lung.org.

American Lung Association ? 55 W. Wacker Drive, Suite 1150 ? Chicago, IL 60601
1331 Pennsylvania Ave. NW, Ste. 1425 North ? Washington, D.C. 20004
1-800-LUNGUSA (1-800-586-4872) Lung.org

SOURCE American Lung Association


These press releases may also interest you

at 07:25
Owlstone Medical ("Owlstone"), the global leader in Breath Biopsy® for applications in early disease detection and precision medicine, today announced it has secured funding from the Bill & Melinda Gates Foundation ("the Gates Foundation" or "the...

at 07:23
Straine Dental Management (SDM), a dentist-owned, dentist-led dental services organization (DSO), continues its national expansion with a strategic affiliation with Jolly Family Dental ? North Little Rock, Arkansas. SDM's entry into its 13th state...

at 07:20
Onconic Therapeutics, a leading biotechnology company in Korea, today announced that the Ministry of Food and Drug Safety (MFDS) of Korea has approved JAQBO (zastaprazan citrate) for the treatment of erosive gastroesophageal reflux disease (GERD) in...

at 07:10
Science Corporation ("Science"), a leader in brain-computer interface ("BCI") technology and the developer of the Science Eye, has acquired the IP and related assets for the PRIMA retinal implant, developed by Pixium Vision SA ("Pixium") of France, a...

at 07:05
GlycoMimetics, Inc. , today announced that it will host a conference call and webcast to report first quarter 2024 financial results on Thursday, May 9, 2024 at 8:30 a.m. ET. To access the call by phone, please go to this registration link and you...

at 07:05
Harrow , a leading U.S. eyecare pharmaceutical company, today announced that it will release its financial results for the first quarter ended March 31, 2024, on Monday, May 13, 2024, after the market close. The Company will also post its first...



News published on and distributed by: